SCHEMBL5717070

SCHEMBL5717070

O=C(O)C1CCCCN1S(=O)(=O)c1ccc(C(F)(F)F)cc1Br

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 2/20 0.56
HCRTR1 O43613 3/20 0.48
HCRTR2 O43614 3/20 0.48
ALDH1A1 P00352 3/20 0.46
HTT P42858 3/20 0.46
BRD4 O60885 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
GAA P10253 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
TSHR P16473 1/20 0.41
CYP2C19 P33261 1/20 0.41
POLB P06746 2/20 0.41
MCL1 Q07820 1/20 0.41
MMP8 P22894 1/20 0.41
MMP12 P39900 1/20 0.41
MMP13 P45452 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5717032 1.00 EPHX2 (0.56) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5717024 0.86 HCRTR1 (0.64) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5717146 0.86 EPHX2 (0.52) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5717147 0.86 EPHX2 (0.52) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5717267 0.84 ALDH1A1 (0.55) EPHX2HCRTR1HCRTR2ALDH1A1SMN1; SMN2
SCHEMBL15010114 0.82 HCRTR1 (0.68) HCRTR1HCRTR2ALDH1A1HTTBRD4
SCHEMBL15010113 0.82 HCRTR1 (0.68) HCRTR1HCRTR2ALDH1A1HTTBRD4
SCHEMBL5716988 0.80 ALDH1A1 (0.66) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5716989 0.80 ALDH1A1 (0.66) EPHX2HCRTR1HCRTR2ALDH1A1HTT
SCHEMBL5717022 0.80 ALDH1A1 (0.66) EPHX2HCRTR1HCRTR2ALDH1A1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1664010-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS Vernalis (R&D) Limited (GB) 2006-06-07 EP disclosed
WO-2005068448-A1 SULFONAMIDES ANTAGONISING N-TYPE CALCIUM CHANNELS IONIX PHARMACEUTICALS LIMITED (GB) 2005-07-28 WO disclosed